EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10–20 scalp electrodes over extended monitoring periods

Taneeta Mindy Ganguly iD, Alan Lai, Andrew Niemiec, Tracy Cameron, Erin C Conrad, Ramya Raghupathi iD, Colin Ellis, Amy J Halliday, Lisa Gillinder iD, Udaya Seneviratne, Patrick Kwan, Piero Perucca iD und 4 weitere

Epilepsia · 2026

DOI: 10.1002/epi.70290 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Epilepsia, 2026. Verfasst von Taneeta Mindy Ganguly und 15 weiteren Autor:innen. Beteiligte Einrichtung: Penn Neuroscience Center-Neurology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Electroencephalography, Electrodes, Implanted, Epilepsy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Medical Research Acceleration Fund, Epiminder Limited.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the signal quality of the Minder implantable continuous EEG monitoring (iCEM) system compared to traditional scalp EEG in the context of long‐term, continuous monitoring in individuals with epilepsy.

Methods

Twenty‐six patients implanted with the Minder iCEM system (November 2019 to July 2023) underwent 7‐day video‐EEG co‐monitoring with full montage scalp EEG at 4 and 24 weeks post‐implantation. Co‐monitored EEG segments were rated for clarity on a 5‐point ordinal scale by blinded expert reviewers for ictal and interictal periods. Minder vs scalp ratings were compared using Wilcoxon signed‐rank test; 4‐ vs 24‐week comparisons used Wilcoxon rank‐sum test. Objective quantitative EEG analysis of the signal bandwidth was performed by application of spectral coherence analysis and Pearson's correlation coefficients.

Results

No significant difference was found between interictal signal clarity reviewer ratings for Minder vs scalp EEG ( p = .97), and there was no statistically significant difference between the Minder signal clarity ratings at 4 vs 24 weeks ( p = .95). Pearson's correlation between Minder vs scalp EEG also indicated a high degree of similarity (median correlation = .69) and no statistically significant difference between correlations at 4 vs 24 weeks ( p = .99). All electrographic seizures identified on full 10–20 scalp EEG were also identified on Minder; however, the full 10–20 montage received statistically higher seizure clarity ratings than Minder ( p < .001). Significance This study supports the feasibility of sub‐scalp EEG as a reliable long‐term monitoring tool. Interictal signal quality was statistically equivalent to limited‐montage scalp EEG, and all seizures identified on full 10–20 scalp EEG were also visualized on Minder. The full 10–20 montage did receive statistically higher seizure clarity ratings, reflecting its greater spatial resolution. The signal quality was stable through 24 weeks, demonstrating the fidelity of the device. These findings position the Minder system as a complement to full montage scalp EEG, particularly in ambulatory settings where continuous long‐term recording is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroencephalographyElectrodes, ImplantedEpilepsyHumansFemaleFeasibility StudiesMaleScalpAdultMiddle AgedYoung AdultSeizures

Stichwörter der Autor:innen

EEGdetectionimplantseizuresubscalp

Autor:innen und Institutionen

  • Penn Neuroscience Center-Neurology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Medicine, St. Vincents Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia.
  • Epiminder Pty Ltd, Melbourne, Victoria, Australia.
  • Department of Clinical Neurosciences, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
  • Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.
  • Neurology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Taneeta Mindy Ganguly, Ramya Raghupathi, Lisa Gillinder, Piero Perucca, Mark J Cook

Förderung

  • Victorian Medical Research Acceleration Fund
  • Epiminder Limited

Zitieren

APA

Ganguly, T. M., Lai, A., Niemiec, A., Cameron, T., Conrad, E. C., Raghupathi, R., Ellis, C., Halliday, A. J., Gillinder, L., Seneviratne, U., Kwan, P., Perucca, P., McGonigal, A., Vogrin, S., Fontenot, H., & Cook, M. J. (2026). Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10–20 scalp electrodes over extended monitoring periods. Epilepsia. https://doi.org/10.1002/epi.70290

Vancouver

Ganguly TM, Lai A, Niemiec A, Cameron T, Conrad EC, Raghupathi R, et al. Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10–20 scalp electrodes over extended monitoring periods. Epilepsia. 2026. doi:10.1002/epi.70290

BibTeX
@article{Ganguly2026,
  author = {Ganguly, Taneeta Mindy and Lai, Alan and Niemiec, Andrew and Cameron, Tracy and Conrad, Erin C and Raghupathi, Ramya and Ellis, Colin and Halliday, Amy J and Gillinder, Lisa and Seneviratne, Udaya and Kwan, Patrick and Perucca, Piero and McGonigal, Aileen and Vogrin, Sara and Fontenot, Holly and Cook, Mark J},
  title = {Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10–20 scalp electrodes over extended monitoring periods},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70290}
}
Kostenlos starten →